News
03-02-2020, 12:23 PM
A study led by the University of Southampton, funded by Cancer Research UK, has shown a new drug - originally developed to tackle the scarring of organ tissue - could help to significantly improve the success rate of cancer immunotherapy treatment.
More... (https://www.news-medical.net/news/20200302/New-dug-could-help-significantly-improve-success-rate-of-cancer-immunotherapy.aspx)
More... (https://www.news-medical.net/news/20200302/New-dug-could-help-significantly-improve-success-rate-of-cancer-immunotherapy.aspx)